Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.

A reactive antibacterial compound is represented by the general formula (I): ##STR00001##
wherein R.sub.1 represents OCN-L-NHCOOR, OCN-L-NHCONHR, OCN-L-NHCOSR, OCN-L-COOR, or OCN-L-COONHR. G1 represents OCN-M-NHCOOG, OCN-M-NHCONHG, OCN-M-NHCOSG, OCN-M-COOG, or OCN-M-COONHG. L, M, R and G independently for each occurrence represent divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. R.sub.4 and G.sub.4 independently for each occurrence represent a divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by at most 18 heteroatoms. G.sub.2 and G.sub.3 independently for each occurrence represent H, F, Cl, Br, I, OCH3, OCH2CH3, OPr, CN, SCN, NO, NO2, a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 7 carbon atoms. Z and X independently for each occurrence represent COO, SO3, or OPO2OR.sub.5. R.sub.5 represents a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 6 carbon atoms.

A reactive antibacterial compound is represented by the general formula (I): ##STR00001##
wherein R.sub.1 represents OCN-L-NHCOOR, OCN-L-NHCONHR, OCN-L-NHCOSR, OCN-L-COOR, or OCN-L-COONHR. G1 represents OCN-M-NHCOOG, OCN-M-NHCONHG, OCN-M-NHCOSG, OCN-M-COOG, or OCN-M-COONHG. L, M, R and G independently for each occurrence represent divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. R.sub.4 and G.sub.4 independently for each occurrence represent a divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by at most 18 heteroatoms. G.sub.2 and G.sub.3 independently for each occurrence represent H, F, Cl, Br, I, OCH3, OCH2CH3, OPr, CN, SCN, NO, NO2, a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 7 carbon atoms. Z and X independently for each occurrence represent COO, SO3, or OPO2OR.sub.5. R.sub.5 represents a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 6 carbon atoms.

A phenalene-1-one compound, a photosensitizer composition including the phenalene-1-one compound, an article including the phenalene-1-one compound and/or photosensitizer composition and the use thereof.

A phenalene-1-one compound, a photosensitizer composition including the phenalene-1-one compound, an article including the phenalene-1-one compound and/or photosensitizer composition and the use thereof.

The present invention provides a nonaqueous electrolytic solution that provides an electric double layer capacitor having excellent durability. The nonaqueous electrolytic solution of the present invention is a nonaqueous electrolytic solution for electric double layer capacitors prepared by dissolving a quaternary ammonium salt as an electrolyte in a nonaqueous solvent, and the nonaqueous electrolytic solution has an alkali metal cation concentration of 0.1 to 30 ppm.

The present invention provides a nonaqueous electrolytic solution that provides an electric double layer capacitor having excellent durability. The nonaqueous electrolytic solution of the present invention is a nonaqueous electrolytic solution for electric double layer capacitors prepared by dissolving a quaternary ammonium salt as an electrolyte in a nonaqueous solvent, and the nonaqueous electrolytic solution has an alkali metal cation concentration of 0.1 to 30 ppm.

The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists. ##STR00001##

The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists. ##STR00001##

A curing agent or a curing accelerator which is easy to synthesize and may cure an epoxy resin and the like, or may accelerate the curing is provided. A curing agent or a curing accelerator according to some embodiments of the present invention has a highly-coordinated silicon structure.